Lisata Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Lisata Therapeutics tiene unos fondos propios totales de $52.7M y una deuda total de $0.0, lo que sitúa su ratio deuda/fondos propios en 0%. Sus activos y pasivos totales son $58.1M y $5.4M respectivamente.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$50.54m |
| Equity | US$47.89m |
| Total liabilities | US$6.80m |
| Total assets | US$54.69m |
Recent financial health updates
Is Lisata Therapeutics (NASDAQ:LSTA) In A Good Position To Deliver On Growth Plans?
Mar 22
We Think Caladrius Biosciences (NASDAQ:CLBS) Needs To Drive Business Growth Carefully
Sep 15We Think Caladrius Biosciences (NASDAQ:CLBS) Needs To Drive Business Growth Carefully
May 02We're Keeping An Eye On Caladrius Biosciences' (NASDAQ:CLBS) Cash Burn Rate
Jan 05Companies Like Caladrius Biosciences (NASDAQ:CLBS) Are In A Position To Invest In Growth
May 09Recent updates
Is Lisata Therapeutics (NASDAQ:LSTA) In A Good Position To Deliver On Growth Plans?
Mar 22We Think Caladrius Biosciences (NASDAQ:CLBS) Needs To Drive Business Growth Carefully
Sep 15Caladrius rallies on approval of merger, name change to Lisata Therapeutics
Sep 14Caladrius Biosciences GAAP EPS of -$0.11 beats by $0.01
Aug 04We Think Caladrius Biosciences (NASDAQ:CLBS) Needs To Drive Business Growth Carefully
May 02We're Keeping An Eye On Caladrius Biosciences' (NASDAQ:CLBS) Cash Burn Rate
Jan 05Companies Like Caladrius Biosciences (NASDAQ:CLBS) Are In A Position To Invest In Growth
May 09Caladrius suspends CLBS119 COVID-19 study
Dec 14Here's Why We're Not Too Worried About Caladrius Biosciences' (NASDAQ:CLBS) Cash Burn Situation
Nov 30
Financial Position Analysis
Pasivos a corto plazo: LSTALos activos a corto plazo ($57.2M) de la empresa superan a sus pasivos a corto plazo ($5.1M).
Pasivo a largo plazo: LSTALos activos a corto plazo ($57.2M) superan a sus pasivos a largo plazo ($253.0K).
Debt to Equity History and Analysis
Nivel de deuda: LSTA está libre de deudas.
Reducción de la deuda: LSTA no tenía deudas hace 5 años.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Cash runway estable: LSTA tiene suficiente margen de tesorería para más de un año basándose en su flujo de caja libre actual.
Pronóstico de cash runway: LSTA dispone de suficiente liquidez para 2.2 años si el flujo de caja libre sigue reduciéndose al ritmo histórico de 2.3% cada año.